Osang Healthcare (036220) has 31 disclosed insider purchases and 1 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩2.3B ($1.6M) in reported transaction value. The earliest filing StockDrifts holds for Osang Healthcare is dated 2024-03-13; the most recent is 2026-05-08. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -17.93%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | BUY | 자사주상여금 | 박미숙 Park Mi-sook | vice president | 500 | - | - | - |
| 2026-05-08 | BUY | 자사주상여금 | 한정 limitation | moving | 150 | - | - | - |
| 2026-04-01 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | ₩8,830 | +15.4% | ₩883K ($613) |
| 2026-01-12 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | ₩11,000 | -7.4% | ₩1M ($764) |
| 2026-01-06 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 200 | ₩11,530 | -11.6% | ₩2M ($2K) |
| 2025-12-23 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | - | - | - |
| 2025-12-22 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 400 | - | - | - |
| 2025-12-12 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | ₩12,310 | -9.4% | ₩1M ($855) |
| 2025-11-26 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | ₩12,560 | -11.2% | ₩1M ($872) |
| 2025-11-07 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | ₩12,410 | -10.2% | ₩1M ($862) |
| 2025-11-05 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | ₩12,710 | -12.3% | ₩1M ($883) |
| 2025-11-04 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | ₩12,950 | -13.9% | ₩1M ($899) |
| 2025-11-03 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 200 | ₩12,730 | -12.4% | ₩3M ($2K) |
| 2025-10-28 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 100 | ₩13,680 | -18.5% | ₩1M ($950) |
| 2025-05-28 | SELL | Market Sell | 김주형 Joohyung Kim | moving | -2.0K | ₩19,900 | +44.0% | ₩40M ($28K) |
| 2025-04-28 | BUY | 자사주상여금 | 손병창 Son Byeongchang | Managing Director | 2.0K | ₩13,470 | -17.2% | ₩27M ($19K) |
| 2025-04-28 | BUY | 자사주상여금 | 박미숙 Park Mi-sook | Managing Director | 500 | ₩13,470 | -17.2% | ₩7M ($5K) |
| 2025-03-25 | BUY | 자사주상여금 | 김주형 Joohyung Kim | moving | 2.0K | ₩14,000 | -20.4% | ₩28M ($19K) |
| 2025-03-25 | BUY | 주식매수선택권 | 김주형 Joohyung Kim | moving | 10.0K | ₩14,000 | -20.4% | ₩140M ($97K) |
| 2025-02-17 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 5.0K | ₩15,070 | -26.0% | ₩75M ($52K) |
| 2025-02-14 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,090 | -26.1% | ₩151M ($105K) |
| 2025-02-13 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,670 | -28.8% | ₩157M ($109K) |
| 2025-02-12 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,870 | -29.7% | ₩159M ($110K) |
| 2025-02-11 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,630 | -28.7% | ₩156M ($109K) |
| 2025-02-10 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,640 | -28.7% | ₩156M ($109K) |
| 2025-02-07 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,920 | -30.0% | ₩159M ($111K) |
| 2025-02-06 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,570 | -28.4% | ₩156M ($108K) |
| 2025-02-05 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 5.0K | ₩15,550 | -28.3% | ₩78M ($54K) |
| 2025-02-04 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 8.0K | ₩15,490 | -28.0% | ₩124M ($86K) |
| 2025-02-03 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,500 | -28.1% | ₩155M ($108K) |
| 2025-01-31 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 11.4K | ₩14,820 | -24.8% | ₩169M ($117K) |
| 2025-01-24 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.6K | ₩14,430 | -22.7% | ₩153M ($106K) |
| 2025-01-24 | BUY | Market Buy | 이종민 Jongmin Lee | Outside Director | 2.0K | ₩14,430 | -22.7% | ₩29M ($20K) |
| 2025-01-23 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,410 | -27.6% | ₩154M ($107K) |
| 2025-01-22 | BUY | Market Buy | 오상자이엘 Oh Sangjaiel | - | 10.0K | ₩15,980 | -30.2% | ₩160M ($111K) |
| 2024-09-27 | BUY | 자사주상여금 | 이의섭 Lee Eui-seop | vice president | 1.0K | ₩12,990 | -14.2% | ₩13M ($9K) |
| 2024-09-27 | BUY | 자사주상여금 | 김주형 Joohyung Kim | moving | 6.0K | ₩12,990 | -14.2% | ₩78M ($54K) |
| 2024-09-27 | BUY | 자사주상여금 | 손병창 Son Byeongchang | Managing Director | 2.0K | ₩12,990 | -14.2% | ₩27M ($18K) |
| 2024-09-10 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 227 | ₩12,990 | -14.2% | ₩3M ($2K) |
| 2024-09-09 | BUY | Market Buy | 강철훈 Kang Cheol-hoon | CEO/President | 1.0K | ₩13,090 | -14.8% | ₩13M ($9K) |
| 2024-06-20 | BUY | Market Buy | 이종민 Jongmin Lee | Outside Director | 2.0K | ₩14,420 | -22.7% | ₩29M ($20K) |
| 2024-03-29 | BUY | 신규선임 | 이종민 Jongmin Lee | Outside Director | 3 | ₩19,970 | -44.2% | ₩60K ($42) |
| 2024-03-26 | BUY | 주식매수선택권 | 홍승억 Seung-Eok Hong | CEO | 40.0K | ₩21,150 | -47.3% | ₩846M ($588K) |
| 2024-03-26 | BUY | 주식매수선택권 | 이의섭 Lee Eui-seop | vice president | 10.0K | ₩21,150 | -47.3% | ₩212M ($147K) |
| 2024-03-26 | BUY | 주식매수선택권 | 손병창 Son Byeongchang | Managing Director | 10.0K | ₩21,150 | -47.3% | ₩212M ($147K) |
| 2024-03-26 | BUY | 주식매수선택권 | 김주형 Joohyung Kim | moving | 5.0K | ₩21,150 | -47.3% | ₩106M ($73K) |
| 2024-03-13 | BUY | PROGRAM | 유병열 Yoo Byung-yeol | Internal director | 50.0K | ₩29,350 | -62.0% | ₩1.5B ($1.0M) |
| 2024-03-13 | BUY | PROGRAM | 이동현 Donghyun Lee | Internal director | 723.6K | ₩29,350 | -62.0% | ₩21.2B ($14.7M) |
| 2024-03-13 | BUY | PROGRAM | 이의섭 Lee Eui-seop | vice president | 15.0K | ₩29,350 | -62.0% | ₩440M ($306K) |
| 2024-03-13 | BUY | PROGRAM | 홍승억 Seung-Eok Hong | CEO | 50.0K | ₩29,350 | -62.0% | ₩1.5B ($1.0M) |
Showing the 50 most recent of 56 filings.
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Osang Healthcare. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.